Invivyd has completed enrollment in the pivotal DECLARATION trial of VYD2311 and reiterates "mid‑year" guidance for results (2Q–3Q 2026); the trial includes a pre‑specified upsizing algorithm that ...
Phoenix NP, a women-focused telehealth medical practice based in Phoenix, Arizona, has announced the availability of FDA-approved Wegovy (semaglutide) as part of its medical weight management services ...
Good day, and thank you for standing by. Welcome to the Invivyd Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results